Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head‐To‐Head Comparison of Lateral Flow and Enzyme‐Linked Immunosorbent Assays
Helicobacter · 2025
DOI: 10.1111/hel.70066 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Helicobacter, 2025. Verfasst von Luochengling Xiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Antibodies, Bacterial, Gastrins, Gastritis, Atrophic, Helicobacter Infections. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
A lateral flow assay (LFA) incorporating several biomarkers, including pepsinogen I (PGI), pepsinogen II (PGII), Gastrin‐17 (G‐17), and Helicobacter pylori IgG, enables the rapid non‐invasive detection of atrophic gastritis (AG). However, its diagnostic performance compared to conventional enzyme‐linked immunosorbent assay (ELISA) has not been established.
Methods
This head‐to‐head comparison study included participants from a prospective and multicenter cohort. Patients with gastric premalignant lesions underwent endoscopy, and fasting serum samples were collected for biomarker analysis using both LFA and ELISA.
Results
A total of 204 patients were included in this study. LFA demonstrated diagnostic specificity for AG comparable to ELISA, with specificity rates of 95.74% (95% CI [85.75%–99.24%]) for LFA and 100.00% (95% CI [92.44%–100.00%]) for ELISA ( p = 0.49). Both methods showed similar performance in detecting H. pylori infection, with an AUC of 0.754 (95% CI [0.616–0.891]) for LFA and 0.778 (95% CI [0.633–0.922]) for ELISA ( p = 0.70). For identifying autoimmune gastritis in corpus AG, a reduced PGI/PGII ratio combined with elevated G‐17 levels provided excellent discrimination, achieving an AUC of 0.926 (95% CI [0.870–0.926]) for LFA and 0.924 (95% CI [0.861–0.924]) for ELISA.
Conclusion
The LFA assay is a feasible, rapid, and non‐invasive tool for assessing gastric functional mucosa. Its diagnostic performance for detecting AG is comparable to ELISA, making it a supplementary tool in point‐of‐care settings to improve the early detection of AG. Trial Registration This study was not registered as a clinical trial, as it is based on an observational study, Progression and Regression of precancerous Gastric Lesions (PROREGAL) study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
ORCID-Profile: Xiaopei Guo, Gwenny M Fuhler
Zitieren
APA
Xiang, L., Zhou, Y., Guo, X., Mommersteeg, M. C., Nieuwenburg, S. A. V., Peppelenbosch, M. P., Spaander, M. C. W., & Fuhler, G. M. (2025). Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head‐To‐Head Comparison of Lateral Flow and Enzyme‐Linked Immunosorbent Assays. Helicobacter. https://doi.org/10.1111/hel.70066
Vancouver
Xiang L, Zhou Y, Guo X, Mommersteeg MC, Nieuwenburg SAV, Peppelenbosch MP, et al. Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head‐To‐Head Comparison of Lateral Flow and Enzyme‐Linked Immunosorbent Assays. Helicobacter. 2025. doi:10.1111/hel.70066
BibTeX
@article{Xiang2025,
author = {Xiang, Luochengling and Zhou, Ying and Guo, Xiaopei and Mommersteeg, Michiel C and Nieuwenburg, Stella A V and Peppelenbosch, Maikel P and Spaander, Manon C W and Fuhler, Gwenny M},
title = {Evaluation of Pepsinogen I, II, Gastrin 17 and Helicobacter pylori IgG in Atrophic Gastritis: A Head‐To‐Head Comparison of Lateral Flow and Enzyme‐Linked Immunosorbent Assays},
journal = {Helicobacter},
year = {2025},
doi = {10.1111/hel.70066}
}
EUVIMED